Financhill
Back

Profound Medical Quote, Financials, Valuation and Earnings

Profound Medical Price Quote

$7.36
+0.01 (+-1.21%)
(Updated: May 3, 2024 at 6:23 AM ET)

Profound Medical Key Stats

Sell
41
Profound Medical (PROF) is a Sell

Day range:
$7.30 - $7.45
52-week range:
$7.11 - $15.49
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.64
P/B ratio:
5.76%

Volume:
22.1K
Avg. volume:
25.2K
1-year change:
-42.71%
Market cap:
$179.6M
Revenue:
$7.2M
EPS:
$-1.35

How Much Does Profound Medical Make?

Is Profound Medical Growing As A Company?

  • What Is Profound Medical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.6%
  • What Is Profound Medical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Profound Medical Stock Price Performance

  • Did Profound Medical Stock Go Up Last Month?
    Profound Medical share price went down by -12.6% last month
  • Did PROF's Share Price Rise Over The Last Year?
    PROF share price fell by -42.71% over the past 1 year

What Is Profound Medical 52-Week High & Low?

Profound Medical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Profound Medical?

  • How Much Debt Does Profound Medical Have?
    Total long term debt quarterly is $7.1M
  • How Much Cash Does Profound Medical Have?
    Cash and short term investments quarterly total is $26.2M
  • What Is Profound Medical’s Book Value Per Share?
    Book value per share is 1.46

Is Profound Medical Cash Flow Positive?

  • What Is PROF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$22.3M
  • What Is Profound Medical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.5M
  • What Is Profound Medical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Profound Medical Return On Invested Capital

  • Is Management Doing A Good Job?
    PROF return on invested capital is -56.95%
  • What Is Profound Medical Return On Assets?
    ROA measures how assets are converting to revenues and is -51.6%
  • What Is PROF Return On Equity?
    ROE is a measure of profitability and is -66.49%

Profound Medical Earnings Date & Stock Price

Profound Medical Competitors

  • Who Are Profound Medical's Competitors?
    Below is a list of companies who compete with Profound Medical or are related in some way:
    • CytoSorbents Corp (CTSO)
    • Delcath Systems Inc (DCTH)
    • Exact Sciences Corp (EXAS)
    • Progyny Inc (PGNY)
    • Star Equity Holdings Inc (STRR)

Profound Medical Dividend Yield

Data Unavailable

Profound Medical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -32.43%
Revenue: 59.83% 3%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 12.92
Upside from Last Price: 75.74%

Major Shareholders

  • How many PROF shares are owned by institutional investors?
    10.5M PROF shares are owned by institutional investors
  • How many PROF shares are owned by insiders?
    0 PROF shares are owned by insiders